Tempe, AZ, United States of America

Bhavani Miryala

This inventor holds 1 USPTO granted patent. Top assignee: Arizona State University. Active years: 2017.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bhavani Miryala: Innovator in Aminoglycoside-Based Polymers

Introduction

Bhavani Miryala is a prominent inventor based in Tempe, AZ (US). She has made significant contributions to the field of polymer science, particularly in the development of lipid-containing aminoglycoside-based polymers. Her innovative work focuses on enhancing drug delivery systems, which can have a profound impact on medical treatments.

Latest Patents

One of her notable patents is titled "Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression." This patent describes a method to form a lipid-containing aminoglycoside-based polymer. The process involves reacting an aminoglycoside with a diepoxide to create an aminoglycoside-based polymeric material. Subsequently, this material is reacted with an acyl chloride to produce the lipid-containing aminoglycoside-based polymer. This invention has the potential to improve the efficacy of drug delivery systems.

Career Highlights

Bhavani Miryala is affiliated with Arizona State University, where she continues her research and development in polymer science. Her work is characterized by a commitment to advancing medical technologies through innovative solutions. With 1 patent to her name, she is recognized for her contributions to the scientific community.

Collaborations

Some of her notable coworkers include Thrimoorthy Potta and Kaushal Rege. Their collaborative efforts contribute to the advancement of research in the field of polymer science and drug delivery systems.

Conclusion

In summary, Bhavani Miryala is an influential inventor whose work in aminoglycoside-based polymers is paving the way for advancements in drug delivery technologies. Her innovative approach and dedication to research continue to inspire progress in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…